These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1455909)

  • 21. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides.
    Johnson S; Opstad NL; Douglas JM; Janoff EN
    Infect Immun; 1996 Oct; 64(10):4339-44. PubMed ID: 8926108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.
    Evenberg D; Hoogerhout P; van Boeckel CA; Rijkers GT; Beuvery EC; van Boom JH; Poolman JT
    J Infect Dis; 1992 Jun; 165 Suppl 1():S152-5. PubMed ID: 1588151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
    Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
    Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines.
    Daum RS; Hogerman D; Rennels MB; Bewley K; Malinoski F; Rothstein E; Reisinger K; Block S; Keyserling H; Steinhoff M
    J Infect Dis; 1997 Aug; 176(2):445-55. PubMed ID: 9237711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm.
    Wu D; Ji S; Hu T
    Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses to pneumococcal capsular polysaccharide: what is being measured?
    Goldblatt D; Jadresic LP; Levinsky RJ; Turner MW
    Immunodeficiency; 1993; 4(1-4):47-50. PubMed ID: 8167732
    [No Abstract]   [Full Text] [Related]  

  • 27. The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity.
    Laferrière CA; Sood RK; de Muys JM; Michon F; Jennings HJ
    Vaccine; 1997 Feb; 15(2):179-86. PubMed ID: 9066036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
    Sanders LA; Rijkers GT; Kuis W; Tenbergen-Meekes AJ; de Graeff-Meeder BR; Hiemstra I; Zegers BJ
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):110-9. PubMed ID: 8423268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits.
    Jansen WT; Verheul AF; Veeneman GH; van Boom JH; Snippe H
    Vaccine; 2001 Oct; 20(1-2):19-21. PubMed ID: 11567741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination.
    Penn RL; Lewin EB; Douglas RG; Schiffman G; Lee CJ; Robbins JB
    Infect Immun; 1982 Jun; 36(3):1261-2. PubMed ID: 7095850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines.
    Siber GR; Anderson R; Habafy M; Gupta RK
    Vaccine; 1995 Apr; 13(6):525-31. PubMed ID: 7483772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immune response in chinchillas to the capsular polysaccharides of Streptococcus pneumoniae.
    Giebink GS; Schiffman G
    Infect Immun; 1983 Feb; 39(2):638-44. PubMed ID: 6832812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.
    Kuo J; Douglas M; Ree HK; Lindberg AA
    Infect Immun; 1995 Jul; 63(7):2706-13. PubMed ID: 7790088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
    Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR
    J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.
    Fattom A; Vann WF; Szu SC; Sutton A; Li X; Bryla D; Schiffman G; Robbins JB; Schneerson R
    Infect Immun; 1988 Sep; 56(9):2292-8. PubMed ID: 3410538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of pneumococcal polysaccharide vaccine in children.
    Obaro S; Leach A; McAdam KW
    Lancet; 1998 Aug; 352(9127):575. PubMed ID: 9716086
    [No Abstract]   [Full Text] [Related]  

  • 38. Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine.
    Mufson MA; Hughey D; Lydick E
    J Infect Dis; 1985 Apr; 151(4):749-50. PubMed ID: 3973424
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1992 Oct; 60(10):4009-14. PubMed ID: 1398913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.